Search Results - Stephen Larsen

  • Showing 1 - 5 results of 5
Refine Results
  1. 1

    Cost-Effectiveness of Extracorporeal Photopheresis in Patients With Chronic Graft-vs-Host Disease by Adrian Peacock, Frances C. Dehle, Oscar A. Mesa Zapata, Francesca Gennari, Maro R.I. Williams, Nada Hamad, Stephen Larsen, Simon J. Harrison, Colman Taylor

    Get full text
    Article


  2. 2

    Real-world Australian experience with tisagenlecleucel for relapsed/refractory diffuse large B-cell lymphoma—importance of pre-CAR-T optimization by Phoebe Joy Ho, Phoebe Joy Ho, Vinay Vanguru, Vinay Vanguru, Cale S. Burge, Rebecca Wayte, Rebecca Wayte, Christina Brown, Christina Brown, Christian E. Bryant, Christian E. Bryant, Scott Dunkley, Scott Dunkley, Derek McCulloch, Derek McCulloch, Liane Khoo, Liane Khoo, James Favaloro, Anthony Jeffrey, Anthony Jeffrey, Annie Solterbeck, Stephen Larsen, Stephen Larsen, Edward Abadir, Edward Abadir

    Published in Frontiers in Oncology (2025-08-01)
    Get full text
    Article


  3. 3

    PB2495: QUANTIFICATION AND IMMUNOPHENOTYPIC CHARACTERISATION OF CAR T-CELLS BY FLOW CYTOMETRY AND CORRELATION WITH CLINICAL OUTCOMES FOR PATIENTS WITH LARGE B CELL LYMPHOMA by Rebecca Wayte, Shihong Yang, Vinay Vanguru, James Favaloro, Christian Bryant, Stephen Larsen, Scott Dunkley, Christina Brown, Katrina Debosz, Elizabeth Reaiche, Emily Anderson, P. Joy Ho, Edward Abadir

    Published in HemaSphere (2023-08-01)
    Get full text
    Article


  4. 4

    A blood dendritic cell vaccine for acute myeloid leukemia expands anti-tumor T cell responses at remission by Jennifer L. Hsu, Christian E. Bryant, Michael S. Papadimitrious, Benjamin Kong, Robin E. Gasiorowski, Daniel Orellana, Helen M. McGuire, Barbara Fazekas de St Groth, Douglas E. Joshua, P. Joy Ho, Stephen Larsen, Harry J. Iland, John Gibson, Georgina J. Clark, Phillip D. Fromm, Derek NJ Hart

    Published in OncoImmunology (2018-04-01)
    Get full text
    Article


  5. 5

    How comparable are patient outcomes in the “real-world” with populations studied in pivotal AML trials? by Ing Soo Tiong, Meaghan Wall, Ashish Bajel, Akash Kalro, Shaun Fleming, Andrew W. Roberts, Nisha Thiagarajah, Chong Chyn Chua, Maya Latimer, David Yeung, Paula Marlton, Amanda Johnston, Anoop Enjeti, Chun Yew Fong, Gavin Cull, Stephen Larsen, Glen Kennedy, Anthony Schwarer, David Kipp, Sundra Ramanathan, Emma Verner, Campbell Tiley, Edward Morris, Uwe Hahn, John Moore, John Taper, Duncan Purtill, Pauline Warburton, William Stevenson, Nicholas Murphy, Peter Tan, Ashanka Beligaswatte, Howard Mutsando, Mark Hertzberg, Jake Shortt, Ferenc Szabo, Karin Dunne, Andrew H. Wei, Australasian Leukaemia and Lymphoma Group (ALLG)

    Published in Blood Cancer Journal (2024-03-01)
    Get full text
    Article


Search Tools: